Search hospitals > Ohio > Akron
Akron Children's Hospital
Claim this profileAkron, Ohio 44308
Global Leader in Cystic Fibrosis
Global Leader in Fibrosis
Conducts research for Syndrome
Conducts research for Mitochondrial Disease
Conducts research for Mitochondrial Myopathy
154 reported clinical trials
11 medical researchers
Summary
Akron Children's Hospital is a medical facility located in Akron, Ohio. This center is recognized for care of Cystic Fibrosis, Fibrosis, Syndrome, Mitochondrial Disease, Mitochondrial Myopathy and other specialties. Akron Children's Hospital is involved with conducting 154 clinical trials across 218 conditions. There are 11 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Rupesh Raina, MD.Top PIs
Steven J. KuerbitzChildren's Hospital Medical Center of Akron7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
48 reported clinical trials
97 drugs studied
Erin WrightChildren's Hospital Medical Center of Akron4 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
40 reported clinical trials
93 drugs studied
Megan Sampson, MDAkron Children's Hospital10 years of reported clinical research
Studies Infections
Studies Viral Diseases
3 reported clinical trials
3 drugs studied
Rupesh Raina, MDAkron Children's Hospital9 years of reported clinical research
Studies Focal Segmental Glomerulosclerosis
2 reported clinical trials
2 drugs studied
Clinical Trials running at Akron Children's Hospital
Focal Segmental Glomerulosclerosis
Muscular Dystrophy
Turner Syndrome
Osteochondritis Dissecans
Osteoarthritis
Viral Diseases
Viral Infections
Viral Reactivation
Infections
Bronchiolitis
LIPOSORBER® LA-15 System
for Focal Segmental Glomerulosclerosis
This trial tests a blood-filtering device called the LIPOSORBER® LA-15 System in adults with kidney issues from FSGS who haven't had success with other treatments or have had severe side effects. The device helps by cleaning the blood to protect the kidneys.
Recruiting1 award N/A2 criteria
Liposorber LA-15 Therapy
for Focal Segmental Glomerulosclerosis
Liposorber® LA-15 System is a blood purification therapy that selectively removes malignant lipoproteins including low density lipoprotein from circulating blood flow and rapidly reduces the plasma cholesterol level. The system was originally developed for the treatment of patients with serious dyslipidemia such as familial hypercholesterolemia and then applied to improve the dyslipidemia, a common complication of nephrotic syndrome and found to bring about improvement not only with the dyslipidemic condition but the nephrotic condition (e.g, proteinuria and hypoproteinemia). Although the definitive mechanism by which the system may relieve nephrotic syndrome is unknown, it has been recognized as one of alternative therapies for refractory nephrotic syndrome including focal segmental glomerulosclerosis (FSGS) in Japan and referred in the Guidelines for the Treatment of Nephrotic Syndrome endorsed by The Japanese Society of Nephrology. This study is conducted as a post approval study imposed by Humanitarian Device Exemption (HDE) order to confirm the safety and efficacy of the Liposorber® LA-15 System in the treatment of drug-resistant pediatric primary FSGS.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Akron Children's Hospital?
Akron Children's Hospital is a medical facility located in Akron, Ohio. This center is recognized for care of Cystic Fibrosis, Fibrosis, Syndrome, Mitochondrial Disease, Mitochondrial Myopathy and other specialties. Akron Children's Hospital is involved with conducting 154 clinical trials across 218 conditions. There are 11 research doctors associated with this hospital, such as Steven J. Kuerbitz, Erin Wright, Megan Sampson, MD, and Rupesh Raina, MD.